Dipna Pharmachem net profit jumps to ₹2.63 cr, steel segment drives earnings
FY26 profit rises from ₹97.40 lakh; steel segment profit surges to ₹866.83 lakh. First-time Ind AS adoption, unmodified audit opinion. Routine filing, no new catalysts.
What's new
- Net profit rose to ₹2.63 cr from ₹97.40 lakh.
- Steel segment profit jumped to ₹866.83 lakh from ₹17.72 lakh; chemicals division posted a loss.
- Auditor gave unmodified opinion; no deviation in preferential issue fund utilisation.
Why this matters
For a ₹19 cr market-cap company, the profit increase is notable, but it's entirely driven by the steel segment. The chemicals division remains a drag. The filing is routine regulatory disclosure, already priced in.
What we're watching
- Sustainability of steel segment profitability in FY27.
- Chemicals division turnaround or continued losses.
- Impact of first-time Ind AS adoption on comparability.
The full read
Dipna Pharmachem's FY26 net profit rose to ₹2.63 crore from ₹97.40 lakh on total income of ₹129.09 crore. That looks strong for a ₹19 crore market-cap company. But the steel segment alone delivered ₹866.83 lakh in profit, up from ₹17.72 lakh. Hardly a diversified story. Meanwhile, the chemicals division lost money – a drag that persists. This is a routine annual filing with an unmodified audit opinion and no deviation in preferential issue proceeds. The first-time adoption of Ind AS adds accounting noise. One segment doing the heavy lifting makes this result more fragile than the headline suggests, and investors should watch whether steel profitability is sustainable into FY27.
Questions answered
- What drove the sharp profit increase in FY26?
- The steel segment's profit surged to ₹866.83 lakh from ₹17.72 lakh, more than covering the chemicals division's loss. Total income grew to ₹129.09 cr from ₹124.93 cr.
- Is this financial information comparable to previous years?
- The company adopted Ind AS for the first time in FY26, so comparisons may be affected. The auditor issued an unmodified opinion.
- Did the company fully utilise proceeds from its preferential issue?
- The board confirmed no deviation in the utilisation of funds raised through the convertible warrants preferential issue.
- How did the chemicals segment perform?
- The chemicals division reported a loss, but the specific figure was not disclosed. The steel segment's strong performance masked the weakness.